Mpox Vaccine Interest Survey Prioritization and Data Flow: Maricopa County, Arizona, July-August 2022

Am J Public Health. 2023 May;113(5):504-508. doi: 10.2105/AJPH.2023.307224. Epub 2023 Mar 9.

Abstract

With increasing mpox cases in Maricopa County, Arizona, the county's health department launched a survey on July 11, 2022, to gather eligibility and contact data and provide clinic information to those interested in JYNNEOS as postexposure prophylaxis (PEP) or expanded postexposure prophylaxis(PEP++). Survey data were matched to case and vaccination data. Overall, 343 of the 513 respondents (66.9%) who reported close contact with an mpox case patient received PEP and 1712 of the 3379 respondents (50.7%) who were unsure of their contact status received PEP++. This outreach intervention connected potential close contacts unknown to MCDPH with PEP or PEP++. (Am J Public Health. 2023;113(5):504-508. https://doi.org/10.2105/AJPH.2023.307224).

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Arizona
  • Humans
  • Mpox (monkeypox)*
  • Smallpox Vaccine*
  • Vaccines*

Substances

  • Smallpox Vaccine
  • Vaccines